In the post-matching data, the invasive treatment strategy (HR = 0.53; 95% CI: 0.35–0.81; p = 0.003) and ACE inhibitor or ARB therapy (HR = 0.58; 95% CI: 0.38–1.89; p = 0.013) remained significant independent predictors of improved survival, whereas diabetes mellitus (HR = 1.88; 95% CI: 1.23–2.87; p = 0.003) and LVEF ≤ 40% (HR = 2.13; 95% CI: 1.40–3.23; p < 0.001) were negative predictors (Table 16). Here, ACE is linked to diabetes mellitus.